Precision diagnostics for every patient

From spatial discovery to routine clinical practice.

Book a demo How the platform works

Problem

The translation gap in diagnostics

Tumour biology, decoded like never before.

Powerful computational and spatial methods are transforming cancer biology, giving researchers a more detailed view of why patients respond differently to the same treatments.

See the science

Too complex to reach the clinic.

High-plex imaging, specialist instruments and heavy computation do not fit into a routine pathology workflow.

Where the gap sits

We built the bridge, from biomarker discovery to clinical deployment.

One platform carries a spatial biomarker through discovery, simplification and clinical deployment, turning research complexity into a diagnostic test deployable in any pathology lab.

How the platform works

From discovery to deployment

One platform for the complete lifecycle of a spatial test.

Capture the full tissue context

High-plex IF maps dozens of biomarkers and morphology from hundreds of patients at once, preserving the biological context of every cell and signal.

The AI model decodes the tumour

Cell phenotypes, spatial patterns and tumour regions are read directly from the multiplex signal, identifying patterns that predict patient outcome.

Keep the signal. Reduce the markers.

The core is unrolled into its channels and the model searches for the smallest marker set that preserves predictive power.

Deploy in clinical practice

Selected markers are converted into routine IHC stains. A model in the Multivision cloud turns them into an actionable risk score that integrates directly into the hospital's digital pathology system.

Test the platform on your own data. Free.

The Decode early release is open now at no cost. Book a 30-minute walkthrough and we set you up, or talk to us about bringing a spatial biomarker toward the clinic. The same platform builds our own diagnostic tests.

Book a demo Get free early access